Brief: Illumina® Protein Prep Launches To Drive Greater Proteomic Insights For Improved Drug Discovery And Development
Sept 3 (Reuters) - Illumina Inc ILMN.O: ILLUMINA® PROTEIN PREP LAUNCHES TO DRIVE GREATER PROTEOMIC INSIGHTS FOR IMPROVED DRUG DISCOVERY AND DEVELOPMENT Source text: ID:nCNWJmSx5a Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Standard BioTools
See all newsBrief: Standard Biotools Announces Agreement To Sell Microfluidics Business To Archimed
Brief: Standard Biotools Provides Update On Sale Of Mass Cytometry Business
Standard BioTools Inc. reports results for the quarter ended June 30 - Earnings Summary
Standard BioTools Q2 revenue falls on consumables weakness
Brief: Standard BioTools Q2 EPS USD -0.07